This inventor holds 1 USPTO granted patent. Top assignee: Egis Gyogyszergyar Rt.. Active years: 1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998
Title: Andrea Sandorfalvy and Pharmaceutical Formulation Innovation.
Introduction
Andrea Sandorfalvy is an inventor associated with Budapest, Hungary, and Egis Gyógyszergyár Rt. His patent work concerns pharmaceutical formulations containing gemfibrozil.
Latest Patents
The supplied information lists one patent for Sandorfalvy: “Gemfibrozil Containing Pharmaceutical Compositions.” The invention describes an oral solid pharmaceutical composition containing gemfibrozil and conventional pharmaceutical auxiliary agents. It uses bis-(2-ethyl-hexyl)-sodium-sulfosuccinate as a surfactant, at 0.05–0.5% by weight relative to the gemfibrozil content. The composition is described as providing uniform dissolution across batches, with a low standard deviation in dissolution rate, while using a relatively small amount of surfactant. The record provided does not specify the patent’s filing or publication date. 1 patent is listed.
Career Highlights
Sandorfalvy’s documented patent contribution focuses on improving the consistency of gemfibrozil dissolution in an oral solid pharmaceutical formulation. The supplied information associates him with Egis Gyógyszergyár Rt., a pharmaceutical company.
Collaborations
The listed coworkers are Denes Bezzegh and Biborka Maroshelyi, née Kovacs. The information provided does not specify their individual roles in the patent.
Conclusion
Andrea Sandorfalvy’s listed patent reflects a formulation-focused innovation aimed at achieving consistent gemfibrozil dissolution while limiting the amount of surfactant used.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile